7240 related articles for article (PubMed ID: 17896605)
21. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
22. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
[TBL] [Abstract][Full Text] [Related]
23. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C.
Raffa G; Maimone S; Cargnel A; Santantonio T; Antonucci G; Massari M; Schiavini M; Caccamo G; Pollicino T; Raimondo G
AIDS; 2007 Oct; 21(16):2171-5. PubMed ID: 18090043
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
25. Major risk of blood transfusion in hemolytic anemia patients.
Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
[TBL] [Abstract][Full Text] [Related]
26. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
Yang RR; Gui X; Chen XY; Zhu Y
J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
[TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
[TBL] [Abstract][Full Text] [Related]
29. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.
Crespo J; Lozano JL; de la Cruz F; Rodrigo L; Rodríguez M; San Miguel G; Artiñano E; Pons-Romero F
Am J Gastroenterol; 1994 Aug; 89(8):1147-51. PubMed ID: 8053425
[TBL] [Abstract][Full Text] [Related]
32. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
[TBL] [Abstract][Full Text] [Related]
33. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
[TBL] [Abstract][Full Text] [Related]
34. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
Gibney KB; Torresi J; Lemoh C; Biggs BA
J Med Virol; 2008 Sep; 80(9):1565-9. PubMed ID: 18649341
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
36. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of occult hepatitis B in Baltimore injection drug users.
Torbenson M; Kannangai R; Astemborski J; Strathdee SA; Vlahov D; Thomas DL
Hepatology; 2004 Jan; 39(1):51-7. PubMed ID: 14752822
[TBL] [Abstract][Full Text] [Related]
38. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
39. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
40. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.
Tripathi AK; Khanna M; Gupta N; Chandra M
J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
